Target intelligence / Profile preview

Glucose transporter (GLUT) (GLUT)

Target
GLUT
Molecular classification
Transporter, Major facilitator superfamily (MFS), Integral membrane protein
01

Overview

The term "Glucose receptors" is not scientifically accurate; the correct target is the **glucose transporter**. Glucose transporters, abbreviated as **GLUTs**, are a family of integral membrane proteins that mediate the facilitated diffusion of glucose and other hexoses across cellular membranes. There are at least 14 known human isoforms, classified into three main classes based on sequence similarity and function. Each isoform has distinct tissue distribution, substrate specificity, and regulatory mechanisms. Class I includes well-characterized members such as **GLUT1** (ubiquitous; basal uptake), **GLUT2** (liver, pancreas; bidirectional transport), **GLUT3** (neurons; high affinity), and **GLUT4** (muscle/adipose; insulin-responsive). These proteins play essential roles in energy metabolism by ensuring appropriate cellular uptake or release of glucose under varying physiological conditions. Alterations in their expression or function are implicated in several diseases including cancer, diabetes mellitus, genetic syndromes like GLUT1 deficiency syndrome, and some neurological disorders[1][3]. Note: The phrase "glucose receptor" is sometimes mistakenly used but does not refer to a recognized molecular entity involved in therapeutic targeting or drug development. The correct targets for drugs affecting blood sugar regulation are typically enzymes involved in metabolism or hormone receptors such as insulin receptor or glucagon-like peptide 1 receptor—not "glucose receptors." Therefore, this entry is marked as incorrect for nomenclature purposes. Key references support that these molecules should be referred to as *transporters* rather than *receptors*[1][6].

Other names
Glucose transporterGLUTSLC2A family (solute carrier family 2)Facilitative glucose transporter
02

Biological functions

Facilitated diffusion of glucose and related hexoses across cell membranes[1][3]Regulation of cellular glucose uptake[1][3]Maintenance of glucose homeostasis[1][3]
03

Disease associations

Cancer (altered expression in tumors)[1][3]Diabetes mellitus (insulin-regulated GLUT4 dysfunction)[1]Genetic diseases linked to specific GLUT isoforms[3]Neurological disorders (e.g., GLUT1 deficiency syndrome)[3]

Beyond the preview

Go deeper on Glucose transporter (GLUT) (GLUT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose transporter (GLUT) (GLUT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call